We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 08, 2020

Rivaroxaban and Aspirin in Patients With Symptomatic Lower-Extremity Peripheral Artery Disease

JAMA Cardiology


Additional Info

JAMA Cardiology
Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial
JAMA Cardiol 2020 Sep 30;[EPub Ahead of Print], E Kaplovitch, JW Eikelboom, L Dyal, V Aboyans, MT Abola, P Verhamme, A Avezum, KAA Fox, SD Berkowitz, SI Bangdiwala, S Yusuf, SS Anand

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading